Improved high-performance liquid chromatographic analysis of terazosin in human plasma
about
Pharmacokinetic and pharmacodynamic consequences of inhibition of terazosin metabolism via CYP3A1 and/or 3A2 by DA-8159, an erectogenic, in rats.Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Prazosin, Terazosin, and Doxazosin in Pharmaceutical Formulations.Thermoanalytical investigation of terazosin hydrochloride.Sensitive determination of terazosin in pharmaceutical formulations and biological samples by ionic-liquid microextraction prior to spectrofluorimetry.
P2860
Improved high-performance liquid chromatographic analysis of terazosin in human plasma
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2000
@uk
name
Improved high-performance liquid chromatographic analysis of terazosin in human plasma
@en
Improved high-performance liquid chromatographic analysis of terazosin in human plasma
@nl
type
label
Improved high-performance liquid chromatographic analysis of terazosin in human plasma
@en
Improved high-performance liquid chromatographic analysis of terazosin in human plasma
@nl
prefLabel
Improved high-performance liquid chromatographic analysis of terazosin in human plasma
@en
Improved high-performance liquid chromatographic analysis of terazosin in human plasma
@nl
P2093
P1476
Improved high-performance liquid chromatographic analysis of terazosin in human plasma
@en
P2093
P304
P356
10.1016/S0378-4347(00)00313-3
P407
P577
2000-08-01T00:00:00Z